Allopregnanolone (Postmenopausal)

The neuroactive metabolite of progesterone, allopregnanolone (AlloP), is higher than range.

→ AlloP is a neuroactive steroid that is created from 5-alpha reductase and 3 alpha hydroxysteroid dehydrogenase metabolism of progesterone.

→ AlloP is formed from progesterone both in the peripheral circulation and directly in the brain. When formed in the peripheral circulation AlloP freely enters the brain through the blood brain barrier and binds to GABAa receptors found in specific gabaergic neurons in the brain.

→ AlloP has a calming (anxiolytic) and sleep-inducing effect at high concentrations. Only high levels of AlloP, achieved at peak of an optimal luteal phase, during pregnancy, and with progesterone therapy, have the anxiolytic effects in the brain. AlloP at low physiological levels can have a paradoxical effect, causing anxiety (anxiogenic) and other symptoms (e.g. anxiety, depression) characteristic of premenstrual dysphoric disorder (PMDD).

--------------------

Elevated levels of allopregnanolone in postmenopausal women can have several implications:

→ Hormonal Changes: Allopregnanolone is a neurosteroid that is derived from progesterone. In postmenopausal women, hormonal changes occur as a result of decreased ovarian function, including lower levels of progesterone. Elevated allopregnanolone levels in this context could indicate an imbalance in hormonal regulation, possibly related to the production or metabolism of neurosteroids like allopregnanolone.

→ Mood and Mental Health: Allopregnanolone is known to have effects on mood and mental health. Elevated levels of allopregnanolone in postmenopausal women might be associated with mood disturbances, such as depression or anxiety, although the relationship is complex and not fully understood.

→ GABAergic Inhibition: Allopregnanolone enhances GABAergic inhibition in the brain, which can influence mood and anxiety. Elevated levels of allopregnanolone may lead to increased GABAergic inhibition, potentially affecting cognitive and emotional functioning.

It's essential to note that more research is needed to fully understand the consequences of elevated allopregnanolone levels in postmenopausal women and their specific effects on health and well-being. Consulting with a healthcare provider for a comprehensive evaluation and appropriate management is recommended when encountering hormonal imbalances.

Allopregnanolone is a neurosteroid hormone that plays a significant role in the context of postmenopausal women. During the menopausal transition, there is a notable reduction in allopregnanolone levels, primarily due to decreased ovarian synthesis of progesterone. This hormonal change can have implications for mood and cognition.